Azelis Group (AZE) H2 2025 earnings summary

Executive summary

• Revenue reached €4.1bn in 2025, up 1.3% in constant currency, with organic revenue declining and market challenges partially offset by four strategic acquisitions across EMEA and APAC.

• Strong free cash flow growth (up 29% to €442m) and disciplined cost and working capital management supported resilience and downside protection.

• Net profit fell to €113m, down 37.6–40.1% year-over-year, mainly due to lower operating profit, higher tax rate, and reduced financial income.

• Capital allocation focused on organic growth, de-leveraging, and maintaining a BB+ credit rating, with a proposed dividend of €0.226 per share.

• Digitalization, innovation, and sustainability advanced, with eight innovation awards and improved ESG ratings (CDP A-, MSCI AA).

Financial highlights

• Revenue: €4.1bn (up 1.3% constant currency, down 2.4% reported); Q4 revenue: €937m (down 7.6%).

• Gross profit: €968m (margin 23.6%, down 91 bp); adjusted EBITA: €411m (margin 10.0%, down 117–170 bp); conversion margin: 42.4%.

• Net profit: €113m (down 37.6–40.1%); EPS €0.46.

• Free cash flow: €442m (up 29–29.2%), cash conversion ratio 106%.

• Leverage ratio: 3.3x net debt/EBITDA (up from 2.9x); net debt stable at €1.6bn.

Outlook and guidance

• Near-term demand remains pressured by macro and geopolitical volatility, but long-term fundamentals in specialty chemicals and ingredients distribution are strong.

• Continued focus on cost, working capital, and readiness to accelerate growth when markets stabilize; deleveraging remains a priority.

• Board proposes a dividend of €0.226 per share.